PromarkerD manufacturing tech-transfer completed – Successful production of components for over 50,000 tests

The Company has successfully produced a pilot batch of PromarkerD test components with specialist immunoassay manufacturer Biotem. Working closely with Proteomics International, Biotem has completed the transfer of the manufacturing process and produced key components to assemble over 50,000 tests for predicting the onset of diabetic kidney disease.

ASX Release


  • This field is for validation purposes and should be left unchanged.